ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today.
Revenues were $15 million, compared to $15.5 million in the prior-year period. Net loss was $24.3 million, or $0.14 per share, compared to a loss of $43.4 million, or $0.29 per share, last year.
For the full year of 2020, revenues are expected to be between $60-65 million.
[irp posts=”59928″]
____
Most Popular
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Target (TGT): A look at some of the challenges faced by the retailer in 3Q24
Shares of Target Corporation (NYSE: TGT) stayed green on Thursday, recovering from the stumble it took a day ago after delivering disappointing results for the third quarter of 2024 and
